SERIES

ADC (Antibody-Drug Conjugate) Series

Antibodies, linkers, and payloads — the mechanism and future of ADCs

---

ADCs (Antibody-Drug Conjugates) combine antibody target selectivity with small-molecule cytotoxicity, representing the flagship of precision medicine. This series covers ADC fundamentals through the latest target strategies, from both clinical and investment perspectives.

📋 Reading Path

1. Basics: ADC Structure and Classification
2. Part 1: Roles of Antibody, Linker, and Payload
3. Applications: Claudin18.2-ADC Development
4. Strategy: Analysis of Approved ADCs
5. Future: Next-Generation ADCs

📚 All Articles in This Series

→ View all articles

🔗 Related Series

Bispecific Antibody Series / CAR-T Series / KRAS Deep Dive / Oncology Approval News